PREVIOUSLY DEVELOPED SYSTEMS-BASED BIOPSY MODEL (PROSTATE PX plus ) IDENTIFIES FAVORABLE-RISK PROSTATE CANCER FOR MEN ENROLLED IN AN ACTIVE SURVEILLANCE PROGRAM

被引：4
|
作者：
Donovan, Michael
Khan, Faisal
Powell, Douglas
Fernandez, Gerardo
Feliz, Aaron
Hansen, Thomas
Bernardino, Lourdes
Capodieci, Paola
Bayer-Zubek, Valentina
Liu, Quihua
Vance, Rav
Klotz, Laurence
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.993
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1293
引用
下载
收藏
页码：E517 / E518
页数：2
相关论文
共 50 条
  • [31] Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer
    Huang, Da
    Ruan, Xiaohao
    Huang, Jingyi
    Zhang, Ning
    Jiang, Guangliang
    Gao, Yi
    Xu, Danfeng
    Na, Rong
    CANCER MEDICINE, 2023, 12 (08): : 9868 - 9878
  • [32] Risk Group and Death From Prostate Cancer Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer
    Raldow, Ann C.
    Zhang, Danjie
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    JAMA ONCOLOGY, 2015, 1 (03) : 334 - 340
  • [33] Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
    Tosoian, J. J.
    Patel, H. D.
    Mamawala, M.
    Landis, P.
    Wolf, S.
    Elliott, D. J.
    Epstein, J. I.
    Carter, H. B.
    Ross, A. E.
    Sokoll, L. J.
    Pavlovich, C. P.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (03) : 339 - 342
  • [34] Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
    J J Tosoian
    H D Patel
    M Mamawala
    P Landis
    S Wolf
    D J Elliott
    J I Epstein
    H B Carter
    A E Ross
    L J Sokoll
    C P Pavlovich
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 339 - 342
  • [35] COMPARISON OF PATHOLOGIC OUTCOMES IN MEN WITH FAVORABLE-RISK PROSTATE CANCER UNDERGOING DELAYED SURGERY AFTER ACTIVE SURVEILLANCE VERSUS IMMEDIATE SURGERY
    Tosoian, Jeffrey
    Sundi, Debasish
    Trock, Bruce
    Landis, Patricia
    Epstein, Jonathan
    Schaeffer, Edward
    Mamawala, Mufaddal
    Carter, H. Ballentine
    JOURNAL OF UROLOGY, 2015, 193 (04): : E757 - E758
  • [36] Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer EDITORIAL COMMENT
    Haas, Gabriel P.
    Delongchamps, Nicolas Barry
    JOURNAL OF UROLOGY, 2012, 188 (03): : 767 - 768
  • [37] Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer
    Degeling, Koen
    Corcoran, Niall M.
    Pereira-Salgado, Amanda
    Hamid, Anis A.
    Siva, Shankar
    IJzerman, Maarten J.
    VALUE IN HEALTH, 2021, 24 (12) : 1737 - 1745
  • [38] Re: Risk Group and Death from Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-Risk Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 196 (02): : 412 - 413
  • [39] Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer
    Gandaglia, Giorgio
    Briganti, Alberto
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2016, 69 (02) : 370 - 370
  • [40] THE USE AND OUTCOMES OF MEN WITH NCCN FAVORABLE INTERMEDIATE RISK PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE
    Paudel, Roshan
    Madan, Raghav
    Qi, Ji
    Cher, Michael
    Lane, Brian
    George, Arvin
    Semerjian, Alice
    Ginsburg, Kevin
    JOURNAL OF UROLOGY, 2022, 207 (05): : E745 - E745
12345